Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
Author:
Funder
Novartis Pharmaceuticals Canada Inc
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference50 articles.
1. Assessing the burden of hospitalized and community-care heart failure in Canada;Blais;Can J Cardiol,2014
2. Outcome of heart failure with preserved ejection fraction in a population-based study;Bhatia;N Engl J Med,2006
3. 2017 comprehensive update of the canadian cardiovascular society guidelines for the management of heart failure;Ezekowitz;Can J Cardiol,2017
4. Gara PTO, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013. https://doi.org/10.1161/CIR.0b013e3182742cf6
5. Relationship between early physician follow-up and 30 day readmission among medicate beneficiaries hospitalized for heart failure;Hernandez;J Am Med Assos,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges in Promoting Health Equity and Reducing Disparities in Access Across New and Established Technologies;Canadian Journal of Cardiology;2024-06
2. Ist Sacubitril/Valsartan bei fortgeschrittener Nierenerkrankung und Dialysepflichtigkeit eine gute Option?;Die Nephrologie;2024-04-09
3. Use of Sacubitril/Valsartan Prior to Primary Prevention Implantable Cardioverter Defibrillator Implantation;CJC Open;2023-01
4. Inpatient Quality-of-Care Measures for Heart Failure: Treatment Gaps and Opportunities in the Contemporary Era;Circulation: Cardiovascular Quality and Outcomes;2022-10
5. The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies;CJC Open;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3